Information for BioSante StockholdersUpon execution of the reverse split, BioSante stockholders will receive one new share of BioSante common stock or class C special stock, as applicable, for every six shares held. Record holders of BioSante common stock will receive a letter of transmittal shortly after the effective date with instructions for the exchange of existing stock certificates for book-entry shares representing the post-reverse split shares. Stockholders with shares in brokerage accounts will be contacted by their brokers with instructions. Computershare Investor Services, LLC, the transfer agent and registrar for BioSante common stock, will act as the exchange agent, and can be contacted at (800) 546-5141 (domestic holders) or 1-781-575-2765 (international holders). Record holders of BioSante class C special stock will receive a letter of transmittal from BioSante shortly after the effective date with instructions for the exchange of existing stock certificates for new stock certificates representing the post-reverse split shares.
BioSante Pharmaceuticals Announces Reverse Stock Split In Order To Maintain NASDAQ Listing
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts